Sleep Disorder Connect
  • Saved
case study

Patient Background:

A 23-year-old woman with childhood-onset Moyamoya disease presented with recurrent seizures and a history of cerebrovascular events. At age 5, she experienced focal motor seizures, initially misattributed to psychogenic causes. By age 7, she developed acute right-sided weakness and aphasia, resulting in residual facial palsy and partial aphasia.

By 2023, exam findings included asthenic habitus, venous insufficiency, mild cognitive impairment (MMSE 26), hyperreflexia (right > left), distal right arm weakness, prosopagnosia, and severe myopia.

Assessment & Diagnosis:

An MRI from 2005 revealed right hemisphere atrophy. In 2006, cerebral angiography confirmed Moyamoya disease, with bilateral carotid artery occlusions and collateral “puff of smoke” vessels. Repeat MRI in 2023 demonstrated chronic ischemic lesions, and angiography confirmed diminished anterior circulation with compensatory collaterals. EEG revealed right-sided background slowing and left temporoparietal epileptiform discharges, consistent with focal seizures. Neuropsychological testing showed mild cognitive disorder with visual–spatial deficits and agnosia.

  1. How is seizure control balanced with stroke prevention in Moyamoya disease?
  2. When is revascularization considered in Moyamoya with seizures, and how is perioperative seizure risk managed?
  • Saved

A 12-week home-based study in atrial fibrillation patients demonstrated high feasibility for decentralized sleep apnoea screening using wearable digital tools, achieving excellent data completeness and patient engagement in remote monitoring.

  • Saved
Functional Neurological Disorder: Advancing Diagnosis and Care for a Complex Neuropsychiatric Condition.

Functional neurological disorder (FND) is a disabling neuropsychiatric condition characterized by involuntary motor, sensory, or cognitive symptoms that are not explained by identifiable structural pathology. Once considered purely psychogenic, FND is now increasingly understood as a condition involving abnormal brain network connectivity and shaped by biopsychosocial factors.

Highlights:

  • FND is the second most common diagnosis in outpatient neurology, disproportionately affecting women and often emerging in early adulthood.
  • Neuroimaging studies reveal altered connectivity in circuits governing emotion, motor control, and self-agency, supporting FND as a genuine brain-based disorder.
  • Symptoms may include functional tremors, gait impairment, non-dermatomal sensory changes, and cognitive difficulties that do not align with classical neurological patterns.
  • Diagnosis increasingly focuses on “positive signs” of internal inconsistency and incongruence during neurologic examination, rather than exclusion of other diseases.
  • Optimal management requires a multidisciplinary approach—including neurology, psychiatry, psychology, and rehabilitation medicine.
  • Emerging predictive imaging techniques may enable future personalization of treatment strategies.

What sets this study apart:

This review underscores the evolution in how FND is diagnosed and treated—shifting from misdiagnosis and stigma toward evidence-based, multidisciplinary care. It highlights the need for early recognition, tailored interventions, and the continued development of objective diagnostic tools.

Limitations:

Challenges remain, including diagnostic uncertainty, persistent stigma, and the absence of standardized imaging protocols or individualized treatment pathways based on neurobiological profiles.

What role could predictive imaging play in guiding individualized treatment plans for FND?

  • Saved
[Hot flashes and sleep disturbances: looking beyond traditional hormone replacement therapy] - PubMed

[Hot flashes and sleep disturbances: looking beyond traditional hormone replacement therapy] - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41103224/

Over the past two years, the introduction of neurokinin-3 receptor antagonists-and the upcoming arrival of neurokinin-1 receptor antagonists-has transformed the therapeutic landscape for menopause, offering more personalized and better-adapted treatment...

This review explores novel non-hormonal therapies, including neurokinin receptor antagonists, for managing menopausal hot flashes and sleep disturbances, summarizing emerging evidence and updated international recommendations for individualized, safer treatment alternatives.

  • Saved
Acute pontine infarction inducing REM sleep behavior disorder: a novel case report - PubMed

Acute pontine infarction inducing REM sleep behavior disorder: a novel case report - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41064372/

Rapid eye movement (REM) sleep behavior disorder (RBD) is parasomnia characterized by the loss of physiological muscle atonia during REM sleep, resulting in dream-enacting behaviors that often manifest as complex,...

A rare case of REM sleep behavior disorder following acute pontine infarction illustrates the brainstem’s essential role in REM regulation and expands understanding of secondary RBD linked to cerebrovascular lesions.